menlo therapeutics
Menlo Therapeutics’ cough drug fails to meet primary endpoint in phase II trial
October 9, 2018Manufacturing and Production Phase II, cough, menlo therapeutics, serlopitant
The Redwood City, California-based late stage biopharmaceutical company Menlo Therapeutics have announced that experimental drug serlopitant has failed to meet …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
